2,3-Diethyl-5-methylpyrazine | CAS:18138-04-0

We serve 2,3-Diethyl-5-methylpyrazine CAS:18138-04-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,3-Diethyl-5-methylpyrazine

Chemical Name:2,3-Diethyl-5-methylpyrazine
CAS.NO:18138-04-0
Synonyms:2,3-Diethyl-5-methylpyrazine
2-Methyl-5,6-diethylpyrazine
2,3-Diethyl-5-methyl-pyrazine
5,6-Diathyl-2-methylpyrazin
2,3-Diethyl-5-methyl-pyrazin
Pyrazine,2,3-diethyl-5-methyl
 
Physical and Chemical Properties:
Density 1.0±0.1 g/cm3
Boiling Point 198.1±35.0 °C at 760 mmHg
Molecular Formula C9H14N2
Molecular Weight 150.221
Flash Point 80.0±0.0 °C
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate



Contact us for information like 2,3-Diethyl-5-methylpyrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrazine,2,3-diethyl-5-methyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Methyl-5,6-diethylpyrazine Use and application,2-Methyl-5,6-diethylpyrazine technical grade,usp/ep/jp grade.


Related News: Because API companies usually adopt a different synthetic route from the original research company, compared with the drug itself, the impurities contained in the generic drug API have not been verified by the original drug for many years of use and require more careful testing and control.3-Pyridylboronic acid manufacturer Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.(alphaR)-alpha-[[[2-(4-Aminophenyl)ethyl]amino]methyl]benzenemethanol hydrochloride supplier Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.4-Bromo-3-methylphenol vendor “So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.”So far, the finding is still under preliminary study, and a large number of experiments is needed to test if it is effective on patients,” it said, citing the WHO in saying that no proven effective drugs to prevent or treat the Wuhan coronavirus are currently available.